ArticleFrontiers in oncology2023

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia.

Sumit Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.